Braun Stacey Associates Inc. Has $5.90 Million Stake in Celsius Holdings Inc. (NASDAQ:CELH)

Braun Stacey Associates Inc. cut its holdings in Celsius Holdings Inc. (NASDAQ:CELH - Free Report) by 43.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 165,745 shares of the company's stock after selling 129,512 shares during the period. Braun Stacey Associates Inc. owned approximately 0.06% of Celsius worth $5,904,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Westside Investment Management Inc. bought a new stake in Celsius in the first quarter worth $32,000. HM Payson & Co. boosted its holdings in Celsius by 122.2% in the fourth quarter. HM Payson & Co. now owns 1,000 shares of the company's stock worth $26,000 after purchasing an additional 550 shares in the last quarter. MassMutual Private Wealth & Trust FSB boosted its holdings in Celsius by 255.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company's stock worth $37,000 after purchasing an additional 750 shares in the last quarter. UMB Bank n.a. boosted its holdings in Celsius by 145.0% in the first quarter. UMB Bank n.a. now owns 1,426 shares of the company's stock worth $51,000 after purchasing an additional 844 shares in the last quarter. Finally, Fifth Third Bancorp boosted its holdings in Celsius by 62.9% in the first quarter. Fifth Third Bancorp now owns 1,725 shares of the company's stock worth $61,000 after purchasing an additional 666 shares in the last quarter. 60.95% of the stock is currently owned by institutional investors.

Insider Activity

In related news, CEO John Fieldly sold 132,171 shares of the stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $43.06, for a total value of $5,691,283.26. Following the completion of the transaction, the chief executive officer owned 1,169,380 shares of the company's stock, valued at $50,353,502.80. This represents a 10.15% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, major shareholder William H. Milmoe sold 300,000 shares of the stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $47.27, for a total transaction of $14,181,000.00. Following the completion of the transaction, the insider directly owned 18,017,770 shares of the company's stock, valued at $851,699,987.90. This trade represents a 1.64% decrease in their position. The disclosure for this sale can be found here. Insiders sold 562,974 shares of company stock valued at $25,758,418 in the last three months. Company insiders own 2.20% of the company's stock.

Celsius Stock Performance

Shares of CELH traded up $0.06 during trading hours on Friday, reaching $46.43. 2,433,913 shares of the company traded hands, compared to its average volume of 8,162,135. The stock's fifty day moving average is $39.91 and its 200 day moving average is $32.95. The stock has a market cap of $11.97 billion, a P/E ratio of 145.08, a price-to-earnings-growth ratio of 1.66 and a beta of 1.45. Celsius Holdings Inc. has a 1-year low of $21.10 and a 1-year high of $60.70.

Celsius (NASDAQ:CELH - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.18 EPS for the quarter, missing analysts' consensus estimates of $0.20 by ($0.02). Celsius had a net margin of 8.40% and a return on equity of 42.12%. The company had revenue of $329.28 million for the quarter, compared to analyst estimates of $349.09 million. During the same period in the prior year, the company posted $0.27 EPS. The firm's quarterly revenue was down 7.4% on a year-over-year basis. On average, equities research analysts predict that Celsius Holdings Inc. will post 0.89 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. Piper Sandler boosted their target price on shares of Celsius from $44.00 to $45.00 and gave the stock an "overweight" rating in a research report on Wednesday, June 4th. Truist Financial upped their price target on shares of Celsius from $45.00 to $50.00 and gave the company a "buy" rating in a report on Friday, June 6th. LADENBURG THALM/SH SH decreased their price target on shares of Celsius from $62.00 to $58.00 and set a "neutral" rating for the company in a report on Thursday, March 27th. JPMorgan Chase & Co. upped their price target on shares of Celsius from $39.00 to $44.00 and gave the company an "overweight" rating in a report on Friday, May 2nd. Finally, TD Cowen upgraded shares of Celsius from a "hold" rating to a "buy" rating and upped their price target for the company from $37.00 to $55.00 in a report on Monday, June 16th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $45.18.

Celsius Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.